Health Trials

Clinical trials

3

Search and review clinical trials. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

The Efficacy and Safety of Intracranial Stent (Tonbridge) in Endovascular Treatment of Symptomatic Intracranial Atherosclerotic Stenosis

The purpose of this study is to verify the efficacy and safety of the Intracranial Stent (Tonbridge) in endovascular treatment of symptomatic intracranial atherosclerotic stenosis.

Participants needed: 200
Trial details
Age: 18-75Biological sex: AllType: InterventionalSponsor: Ton-Bridge Medical Tech. Co., LtdUpdated: Jan 2, 2026Locations: 13
Eligibility criteria

Age 18-75; [+9]

Intracranial arterial stenosis caused by non-atherosclerotic lesions: such as ar... [+17]

Read more
Status: Not yet recruiting

Evaluation of a Novel Intrasaccular Embolization Device for the Treatment of Intracranial Aneurysms

The study is a prospective, multicenter single-arm cohort. The purpose of this study is to evaluate efficacy and safety of a novel intrasaccular embolization device for the treatment of intracranial aneurysms.

Participants needed: 150
Trial details
Age: 18-75Biological sex: AllType: InterventionalSponsor: Ton-Bridge Medical Tech. Co., LtdUpdated: Jun 15, 2025
Eligibility criteria

Patient must be 18-75 years of age at the time of screening. [+2]

Patient had an IA with characteristics unsuitable for endovascular treatment. [+5]

Read more
Status: Recruiting

Efficacy and Safety of the Liquid Embolic System (Tonbridge) for Endovascular Treatment of Cerebrovascular Malformations

The purpose of this study is to verify the efficacy and safety of the Liquid Embolic System (Tonbridge Medical Tech. Co., Ltd. (Suzhou)) for the treatment of cerebrovascular malformations.

Participants needed: 170
Trial details
Age: 18-80Biological sex: AllType: InterventionalSponsor: Ton-Bridge Medical Tech. Co., LtdUpdated: Sep 19, 2024Locations: 14
Eligibility criteria

Age 18 to 80 years, any gender; [+2]

Intracranial hemorrhage within 1 month prior to treatment; [+11]

Read more